
Dr. Sara El Ouali, MD, is a consultant staff physician in the Digestive Disease Institute at Cleveland Clinic Abu Dhabi and at Cleveland Clinic Ohio, and a Clinical Assistant Professor of Medicine at Cleveland Clinic Lerner College of Medicine, Case Western Reserve University in Cleveland, Ohio.
Dr. El Ouali earned her medical degree from McGill University in Montreal, Canada during which she was awarded several scholarships for academic excellence. She completed her Internal Medicine residency at the McGill University Health Center, where she was awarded the Ezra Lozinski prize in recognition of her outstanding compassion, understanding and sense of responsibility. She completed her Gastroenterology & Hepatology fellowship as Chief Resident at McGill University, and then underwent an advanced inflammatory bowel disease fellowship at the Cleveland Clinic in Ohio.
Dr. El Ouali has published numerous articles and book chapters and presents at major international conferences. She is actively involved in IBD research and academic activities. She is associate editor of the IBD Journal and is also part of the editorial team of several gastroenterology journals. She has founded the first patient education program for IBD in the UAE in 2018. In 2022, Dr. El Ouali won the "Rising Star" award in recognition of her ongoing clinical and academic contributions to CCAD and in 2023, she won the “Outstanding quality of Care” award at Cleveland Clinic Abu Dhabi.
Selected publications from PubMed
Entering a new GALAXI: The importance of long-term data in Crohn's disease clinical trials.
Sleiman J, El Ouali S, Noor NM
Inflamm Bowel Dis. 2026 Jul 1;32(7):1423-1425 doi: 10.1093/ibd/izag073.
Development of a Computed Tomography Enterography-Based Radiomics Model to Characterize Inflammation, Fibrosis, and Smooth Muscle Thickening in Stricturing Crohn's Disease.
Sleiman J, Pillai VG, Chirra P, Gandhi NS, Gordon IO, Hariri M, Baker ME, Ream J, Fulmer C, El Ouali S, Bruining DH, Kurowski JA, Rieder F, Viswanath SE, Stenosis Therapy and Anti-Fibrotic Research (STAR) Consortium
Am J Gastroenterol. 2026 Jun 9 doi: 10.14309/ajg.0000000000004073.
Vedolizumab for stricturing Crohn's disease of the terminal ileum - an international multicenter cohort study.
El Ouali S, Baker ME, Lu C, Medellin A, Bruining DH, Fletcher JG, Inoue A, Regueiro M, Ottichilo RK, Schoenoff S, Rosentreter R, Bena J, Qazi T, Holubar SD, Gauriloff S, Gandhi NS, Falloon K, Sleiman J, Cohen BL, Goren I, Balci N, Rieder F, Stenosis Therapy and Anti-Fibrotic Research (STAR) Consortium
BMC Gastroenterol. 2026 May 20;26(1) doi: 10.1186/s12876-026-04815-4.
Toward a United Arab Emirates national inflammatory bowel disease transition care pathway: Findings from a healthcare professional survey and development of evidence-based tools.
Quraishi MN, Bitar R, El Ouali S, Nathwani RA, Koutoubi Z, Jazzar A, El-Gazzar Y, Al Awadhi S, Al Hassani A, Omar NM, Tzivinikos C, UAE IBD Transition Survey Group, UAE IBD Transition Survey Group
Saudi J Gastroenterol. 2026 Apr 24 doi: 10.4103/sjg.sjg_41_26.
Diagnosis and Management of Upper Gastrointestinal Involvement in Adult Patients With Crohn's Disease: A Systematic Review.
Cohen NA, Sror N, Naseer M, Bettenworth D, Lu C, Khedraki R, Abreu MT, Atreya R, Al-Bawardy B, Connor SJ, d'Haens G, Dotan I, Dignass A, El Ouali S, Feagan B, Feakins R, Gearry R, Gordon IO, Hedin C, Kobayashi T, Leibovitzh H, Maharshak N, Ollech J, Sebastian S, Siegmund B, Rubin DT, Silverberg MS, Steinwurz F, Torres J, Watermeyer G, Hernandez-Rocha C, Gurizzian P, Silfen A, Tzadok R, Falloon K, Rieder F
Clin Gastroenterol Hepatol. 2026 Apr;24(4):932-948 doi: 10.1016/j.cgh.2025.03.024.

Welcome & Introduction – Dr. Steven D. Wexner (USA) Combination therapy – Treat the intestinal mucosa to treat the fistula - Dr. Sara El Ouali (UAE/USA) Who is a candidate for stem cells? - Dr. Julián Panés (Spain) Practical tips for optimizing the success of stem cell therapy - Dr. Louis J. Cohen (USA) Patient-reported outcomes in fistula surgery - Dr. Marylise Boutros (Canada) The results of stem cells for anal fistulas – Dr. Giovanna da Silva (USA) Video stem cells for anal fistulas - Dr. Phillip Fleshner (USA) Panel discussion & Closing Remarks - All faculty moderated by Dr. Steven D. Wexner (USA) *Supported by an educational grant from Takeda Pharmaceuticals U.S.A.
With Takeda
Published
Jul 2023

One of the most vexing problems encountered by colorectal surgeons and gastroenterologists is anal fistulas. The myriad techniques and technologies available are evidence that there is no one solution. The constant quest for a cure of fistula without sacrificing continence has led to a wide range of advances. The internationally renowned experts in this session will discuss the evaluation as well as the medical and surgical management of anal fistulas, including the most feared complication following fistula surgery for fecal incontinence.
With Takeda
Published
Sep 2021
Help your network discover Dr. Sara El Ouali's clinical expertise.